Stephen Chia Selected Research

Formaldehyde (Formol)

1/2012	Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial.
6/2004	A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen Chia Research Topics

Disease

48	Breast Neoplasms (Breast Cancer) 09/2021 - 12/2003
27	Neoplasms (Cancer) 01/2022 - 11/2003
4	Pathologic Complete Response 12/2020 - 08/2009
4	Cardiotoxicity 01/2009 - 10/2005
3	Neutropenia 01/2021 - 01/2010
2	Carcinogenesis 09/2021 - 11/2005
2	Neoplasm Metastasis (Metastasis) 02/2021 - 05/2011
2	Disease Progression 01/2021 - 01/2019
2	Exanthema (Rash) 01/2017 - 09/2009
2	Brain Neoplasms (Brain Tumor) 06/2012 - 11/2009
1	Colorectal Neoplasms (Colorectal Cancer) 09/2021
1	Nausea 01/2020
1	Vomiting 01/2020
1	Hyperglycemia 11/2018
1	Leukopenia 01/2018
1	Triple Negative Breast Neoplasms 04/2012
1	Acidosis 05/2011
1	Hypoxia (Hypoxemia) 05/2011
1	Hypertension (High Blood Pressure) 01/2010
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2010
1	Cough 09/2009
1	Anorexia 09/2009
1	Diarrhea 09/2009
1	Stomatitis 09/2009
1	Fatigue 09/2009
1	Pneumonia (Pneumonitis) 09/2009

Drug/Important Bio-Agent (IBA)

15	Hormones (Hormone)IBA 02/2021 - 04/2008
10	Fulvestrant (Faslodex)FDA Link 01/2021 - 04/2008
10	Trastuzumab (Herceptin)FDA Link 11/2019 - 04/2004
8	Biomarkers (Surrogate Marker)IBA 09/2021 - 08/2009
7	Estrogen ReceptorsIBA 01/2022 - 12/2003
7	Aromatase InhibitorsIBA 01/2021 - 04/2008
6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 04/2004
6	Pharmaceutical PreparationsIBA 01/2020 - 06/2005
4	N-acetyltalosaminuronic acid (NAT)IBA 01/2020 - 03/2014
4	human ERBB2 proteinIBA 01/2020 - 12/2008
4	Proteins (Proteins, Gene)FDA Link 05/2011 - 11/2003
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 06/2004
3	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 12/2003
3	Epidermal Growth Factor (EGF)IBA 02/2021 - 01/2017
3	exemestane (Aromasin)FDA Link 01/2019 - 04/2008
3	AnthracyclinesIBA 01/2018 - 01/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2009 - 06/2005
3	liposomal doxorubicin (Doxil)FDA Link 08/2007 - 06/2005
2	Phenobarbital (Luminal)FDA Link 01/2022 - 05/2015
2	Bevacizumab (Avastin)FDA Link 09/2021 - 06/2012
2	Everolimus FDA Link 09/2021 - 09/2009
2	AlpelisibIBA 01/2021 - 01/2021
2	Cyclin-Dependent Kinase 4IBA 01/2021 - 01/2021
2	ribociclibIBA 01/2020 - 01/2018
2	Carbonic Anhydrase IXIBA 01/2020 - 05/2011
2	Immune Checkpoint InhibitorsIBA 11/2019 - 08/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 06/2004
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2018 - 01/2017
2	Alanine Transaminase (SGPT)IBA 11/2018 - 01/2017
2	NVP-BKM120IBA 11/2018 - 01/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2018 - 01/2017
2	pertuzumabIBA 01/2018 - 07/2014
2	PlatinumIBA 12/2017 - 08/2009
2	RNA (Ribonucleic Acid)IBA 10/2015 - 02/2006
2	Fluorouracil (Carac)FDA LinkGeneric 01/2012 - 04/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 04/2009
2	ParaffinIBA 01/2012 - 06/2004
2	Formaldehyde (Formol)FDA Link 01/2012 - 06/2004
2	Docetaxel (Taxotere)FDA Link 04/2009 - 01/2009
2	1-dodecylpyridoxal (PLD)IBA 08/2007 - 06/2006
2	Drug CombinationsIBA 06/2005 - 04/2004
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2021
1	Capecitabine (Xeloda)FDA Link 09/2021
1	neratinibIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	SLC-0111IBA 01/2020
1	BenzenesulfonamidesIBA 01/2020
1	durvalumabIBA 11/2019
1	B7-H1 AntigenIBA 11/2019
1	Circulating Tumor DNAIBA 01/2019
1	thymidine kinase 1IBA 01/2019
1	Coloring Agents (Dyes)IBA 05/2015
1	taxaneIBA 03/2014
1	Monoclonal AntibodiesIBA 06/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012
1	Epirubicin (Ellence)FDA LinkGeneric 01/2012
1	Methotrexate (Mexate)FDA LinkGeneric 01/2012
1	Small Interfering RNA (siRNA)IBA 05/2011
1	CaspasesIBA 05/2011
1	pazopanib FDA Link 01/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2010
1	TOR Serine-Threonine KinasesIBA 09/2009
1	Biological ProductsIBA 09/2009
1	OGX-011IBA 01/2009

Therapy/Procedure

21	Therapeutics 09/2021 - 08/2007
11	Drug Therapy (Chemotherapy) 09/2021 - 01/2009
6	Neoadjuvant Therapy 12/2020 - 03/2014
1	Drug Tapering 01/2021
1	Operative Time 01/2021
1	Mastectomy (Mammectomy) 12/2020
1	Segmental Mastectomy (Lumpectomy) 12/2020
1	Immunotherapy 08/2019